Yongcan Guo

Dr. Yongcan Guo

orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2018 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
STSitian Tang
Sitian Tang
HSHuawei Shen
Huawei Shen
YHYixiong Hao
Yixiong Hao
ZHZhenglan Huang
Zhenglan Huang
YTYiyi Tao
Yiyi Tao
WFWenli Feng
Wenli Feng

1 July 2010 in Cancer Genetics and Cytogenetics
Verified
Journal Article
Closed access
LOLiping Ou
Liping Ou
YGYongcan Guo
Yongcan Guo
CLChunli Luo
Chunli Luo
XWXiaohou Wu
Xiaohou Wu
YZYi Zhao
Yi Zhao
XCXiaozhong Cai
Xiaozhong Cai

1 August 2018 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
TDTao Dai
Tao Dai
QPQinli Pu
Qinli Pu
YGYongcan Guo
Yongcan Guo
CZChen Zuo
Chen Zuo
SBShulian Bai
Shulian Bai
GXGuoming Xie
Guoming Xie

30 December 2019 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YJYao Jiang
Yao Jiang
JHJimin He
Jimin He
YGYongcan Guo
Yongcan Guo
HTHualin Tao
Hualin Tao
FPFei Pu
Fei Pu
YLYiqin Li
Yiqin Li

1 February 2019 in Microchimica Acta
Verified
Journal Article
Closed access
PDF file
QPQinli Pu
Qinli Pu
XYXuanhua Yang
Xuanhua Yang
YGYongcan Guo
Yongcan Guo
TDTao Dai
Tao Dai
TYTingyan Yang
Tingyan Yang
GXGuoming Xie
Guoming Xie

26 February 2021 in RSC Advances
Verified
Journal Article
Open access
PDF file
CZChen Zuo
Chen Zuo
YGYongcan Guo
Yongcan Guo
JLJunjie Li
Junjie Li
ZPZhiping Peng
Zhiping Peng
SBShulian Bai
Shulian Bai
GXGuoming Xie
Guoming Xie
Multifunctional nano-materials that can be used to monitor the expression of specific biomarkers and serve as vehicles for controlled drug delivery are highly desirable. Herein, we report a new DNA-hybrid-gated core–shell upconversion nanoprobe (UCNP@MOF/DOX) for fluorescence analysis of microRNA-21 (miR-21), which also triggers the release of drug loaded in the probes for on-demand anti-cancer treatment. The nanoprobe is built on the merits of ultraviolet-visible light of upconversion nanoparticles (UCNPs) excited by near-infrared (NIR) and extraordinary loading capability of metal–organic frameworks (MOFs) for drug delivery. Controlled release of doxorubicin (DOX) from the nanoprobe by miR-21 underwent the following two-stage kinetics: a fast release stage specifically triggered by miR-21 and proportional to miR-21 concentration and a slow stage observed in both gated and ungated nanoprobes due to collapse of the UIO-66-NH2 coatings via ligand exchange with phosphates. In addition, the nanoprobe showed good selectivity, a linear response towards miR-21 ranging from 4 nM to 500 nM, and a limit of detection in 4 nM, which precluded unintended payload leakage due to low-abundance endogenous miR-21 expression in normal cells. Moreover, based on a dual-targeted delivery system constituted by AS1411-mediated recognition and responsive release of DOX, a specific cytotoxic efficacy was observed in MCF-7 cells. The present work provides a smart and robust nanoprobe for real-time detection of miRNA and dual-responsive drug delivery in tumor cells.